Literature DB >> 12383518

Identification, localization and receptor characterization of novel mammalian substance P-like peptides.

Marc M Kurtz1, Ruiping Wang, Michelle K Clements, Margaret A Cascieri, Christopher P Austin, Barry R Cunningham, Gary G Chicchi, Qingyun Liu.   

Abstract

Hemokinin-1 (HK-1) is a novel substance P (SP)-like peptide that is encoded by the preprotachykinin C (PPT-C) gene recently identified in mouse B cells and shown to be a potentially important regulator of B cell development (Nat. Immunol. 1 (2000) 392). We have now isolated and characterized the human and rat orthologs of PPT-C and examined activities of human and mouse HK-1 on the three tachykinin receptors, neurokinin-1-3 (NK1-3). The rat PPT-C polypeptide is highly homologous to mouse PPT-C and contains the same processing sites to generate predicted HK-1. The human PPT-C polypeptide is also homologous to mouse PPT-C, however, it contains two potential monobasic cleavage sites rather than a single dibasic cleavage site at the amino-terminal end of the predicted HK-1 peptide. Thus, human PPT-C has the potential to generate full length predicted HK-1 as well as a truncated version (HK-1(4-11)). Polymerase chain reaction analysis revealed that both human and mouse PPT-C were expressed in a variety of tissues with strong signals detected in the skin of both species and in the mouse brain. Binding and functional analysis indicated that human and mouse HK-1 peptides were nearly identical to SP in their overall activity profile on the three NK receptors with the most potent affinity for the NK1 receptor. The results indicate that PPT-C encodes another high affinity ligand of the NK1 receptor which may play an important role in mediating some of the physiological roles previously assigned to the NK1 receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383518     DOI: 10.1016/s0378-1119(02)00861-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  23 in total

Review 1.  G protein-coupled receptors as oncogenic signals in glioma: emerging therapeutic avenues.

Authors:  A E Cherry; N Stella
Journal:  Neuroscience       Date:  2014-08-24       Impact factor: 3.590

Review 2.  Tachykinins and excitotoxicity in cerebellar granule cells.

Authors:  Cinzia Severini; Cristina Zona
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

3.  Increase in hemokinin-1 mRNA in the spinal cord during the early phase of a neuropathic pain state.

Authors:  T Matsumura; A Sakai; M Nagano; M Sawada; H Suzuki; M Umino; H Suzuki
Journal:  Br J Pharmacol       Date:  2008-07-28       Impact factor: 8.739

Review 4.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 5.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

6.  Contractile effect of tachykinins on rabbit small intestine.

Authors:  Marta Sofía Valero; Diego Santos Fagundes; Laura Grasa; María Pilar Arruebo; Miguel Ángel Plaza; María Divina Murillo
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

7.  Neurokinin-1 receptor directly mediates glioma cell migration by up-regulation of matrix metalloproteinase-2 (MMP-2) and membrane type 1-matrix metalloproteinase (MT1-MMP).

Authors:  Lingyun Mou; Yawei Kang; Ying Zhou; Qian Zeng; Hongjing Song; Rui Wang
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

8.  Tachykinins and tachykinin receptors in human uterus.

Authors:  Eva Patak; M Luz Candenas; Jocelyn N Pennefather; Sebastian Ziccone; Alison Lilley; Julio D Martín; Carlos Flores; Antonio G Mantecón; Margot E Story; Francisco M Pinto
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

9.  Mouse Hemokinin-1 Decapeptide Subjected to a Brain-specific Post-translational Modification.

Authors:  Georgia Deliconstantinos; Stephen Barton; Mikhail Soloviev; Nigel Page
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

10.  Changes in the disposition of substance P in the rostral ventromedial medulla after inflammatory injury in the rat.

Authors:  U P Maduka; M V Hamity; R Y Walder; S R White; Y Li; D L Hammond
Journal:  Neuroscience       Date:  2016-01-04       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.